DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ shed 3.41% to $150.03 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,051.09 and the Dow Jones Industrial Average falling 0.20% to 43,828.06.
This was the stock's second consecutive day of losses.
Biogen Inc. closed $118.27 below its 52-week high ($268.30), which the company achieved on January 3rd.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.26% to $146.62 and Pfizer Inc. $(PFE)$ rose 0.83% to $25.58.
Trading volume (1.6 M) eclipsed its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 13, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 13, 2024 17:07 ET (22:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments